about
Apoptotic pathways as a therapeutic target for colorectal cancer treatmentPhotoreceptor cell death and rescue in retinal detachment and degenerationsBiomarkers and molecular probes for cell death imaging and targeted therapeuticsQD-Based FRET Probes at a GlanceMarine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosisTargeting the apoptosis pathway in hematologic malignanciesPreclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgarisStructural basis for executioner caspase recognition of P5 position in substratesDiscovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)"Eat me" imaging and therapySynthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell linesApoptosis-related genes change their expression with age and hearing loss in the mouse cochlea.Spirotetronate polyketides as leads in drug discovery.Straw blood cell count, growth, inhibition and comparison to apoptotic bodiesMitochondrial and postmitochondrial survival signaling in cancer.The potential for caspases in drug discoveryIn vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of actionA dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.Induction of apoptosis and inhibition of cell growth by tbx5 knockdown contribute to dysmorphogenesis in Zebrafish embryos.A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoValidation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot studyProteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applicationsInducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocagesSynthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activityOncolytic virotherapy for ovarian cancer.Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure.Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic responseEnhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured MacrophagesFused Bicyclic Caspase-1 Inhibitors Assembled by Copper-Free Strain-Promoted Alkyne-Azide Cycloaddition (SPAAC).Targeting apoptosis with dietary bioactive agents.Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate.Reactive-site cleavage residues confer target specificity to baculovirus P49, a dimeric member of the P35 family of caspase inhibitors.Apoptosis pathways as promising targets for skin cancer therapy.Melanocyte receptors: clinical implications and therapeutic relevance.Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.Cytoprotective effects of IAPs revealed by a small molecule antagonist.Redox regulation of cell survivalTo kill a tumor cell: the potential of proapoptotic receptor agonistsCell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction
P2860
Q26738304-568A843D-B7BD-4342-A162-5CA8D750EA47Q26853192-175C947E-7A56-49C0-9210-5894969850A1Q26866387-5CE9962E-CEF4-4D12-8874-0306A5699203Q26995327-A279D79A-0DE8-4F15-984C-B6C6E962FCCDQ27021618-EB605A28-FB36-477D-A5F2-32CABA9F31F1Q27024422-16290BB5-1EC3-4999-BF40-EAC0B11C1347Q27311634-F19CE848-EE32-49D4-A50C-5BFE9ABD6E42Q27652050-7D96E142-3390-4180-9934-FA2862DAC06DQ27678027-DF7BD676-C03B-428D-8533-EF9EF7E1B13DQ28394148-8B9AA82B-AFC4-4BCB-BBB8-76B120D59B07Q28543401-53C6F9F7-F25E-4DCF-82F2-F4CD76BB080AQ30482886-1B4F448B-A11F-4D08-943E-8B58F982518CQ30872494-627532D3-6D7C-4E78-AFAA-FDAA583FAFDBQ33336245-FAD84A43-0C49-4629-8332-93076D1BA511Q33645577-395FF0E1-CDCA-42A7-A2E6-302020055E10Q33682384-D69B5F78-15FF-406B-A3F9-7878728BBBF2Q33690770-E30EDF93-13DA-40CB-86F4-AA0E95E036EFQ33847443-38E299D0-E74C-423E-951D-1BC1B882AC01Q34044016-749D472D-7287-4A31-93AA-7E433114A4ACQ34241381-A55BBC55-368B-494B-B416-F267540F0CBCQ34279510-8BC8295F-3173-4D84-A9F4-C6790AF2C77FQ34301831-0DAF052A-2E75-411B-A5EF-2D0E6684C647Q34476390-5BA7E63F-8AE9-4237-944D-8DE7F4554486Q34777281-4D0E9773-0F05-42E8-8100-11CD3BE4D5C0Q35111443-7674475C-A9F6-4D7B-8E59-F0BA32B398C7Q35597082-7845BDEA-07E1-4DD6-A1F1-FD62617C913CQ35960932-C77AC6D5-3BD4-47B2-93E3-E5C32FAA01E4Q36030459-57E4F517-4199-4D1F-933E-ABFA681C75BFQ36058714-D45F6709-AAF6-4EB4-99CA-B1C745864D11Q36203227-133C68AC-BB55-41C8-A63B-C5B65FD42892Q36381878-254BB5FF-7248-4391-BE56-A4981AAC4AAFQ36724891-433C3DE7-8056-4A01-8E39-AABB8CF98C0EQ36804644-3201B3A4-99B2-43E4-AEB7-7F4A321167EDQ36815310-0A8DCF33-EE96-4D61-AC7E-5941E07564BCQ36954814-5ADAE792-A2ED-4959-B549-0EFB5D0E2289Q36988138-9FF39C55-5652-4196-B591-346AC6EFBFD6Q37172657-49654189-E561-40C9-B1DA-5B5274E2973DQ37181226-93C34142-989C-4C8C-8338-FBCFA428F91CQ37181734-F8515675-565A-485B-85FF-373496F5D48EQ37279896-F940317B-CBFC-435E-983C-227B398CA606
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Apoptosis-based therapies and drug targets.
@ast
Apoptosis-based therapies and drug targets.
@en
type
label
Apoptosis-based therapies and drug targets.
@ast
Apoptosis-based therapies and drug targets.
@en
prefLabel
Apoptosis-based therapies and drug targets.
@ast
Apoptosis-based therapies and drug targets.
@en
P2860
P356
P1476
Apoptosis-based therapies and drug targets.
@en
P2093
Schulze-Osthoff K
P2860
P2888
P304
P356
10.1038/SJ.CDD.4401556
P478
12 Suppl 1
P577
2005-08-01T00:00:00Z